Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Nurs Stand ; 21(2): 47-56; quiz 58, 2006.
Article in English | MEDLINE | ID: mdl-17016998

ABSTRACT

This article examines the development of primary percutaneous coronary intervention (PPCI) for the treatment of acute ST-segment elevation myocardial infarction in the UK. It discusses the evidence related to PPCI, the technological advances to improve accessibility to this treatment and the nursing care of a patient undergoing this procedure.


Subject(s)
Angioplasty, Balloon, Coronary/statistics & numerical data , Myocardial Infarction/therapy , Education, Continuing , Humans , Myocardial Infarction/nursing , Myocardial Infarction/physiopathology , Telemedicine , Triage , United Kingdom
2.
Can J Anaesth ; 39(6): 563-8, 1992 Jul.
Article in English | MEDLINE | ID: mdl-1643679

ABSTRACT

Shivering after cardiac surgery can produce adverse haemodynamic and metabolic sequelae. In this study, the metabolic effects of shivering and the efficacy of treatment with meperidine or pancuronium were studied, using a metabolic cart, in 61 patients who had undergone cardiac surgery. The patients received premedication with morphine, perphenazine and diazepam or lorazepam, and were anaesthetised with fentanyl or sufentanil and diazepam. Muscle relaxation was achieved with pancuronium. Patients were monitored with a radial arterial line, pulmonary artery catheter and oesophageal and urinary bladder temperature probes. Rewarming to an oesophageal temperature of 38 degrees C was achieved before the termination of CPB and was maintained for a minimum of 15 min reperfusion time. Every 15 min after surgery, the patients' temperature at three sites (pulmonary artery, oesophagus, bladder) and shivering scores were monitored. Hourly measurements were made of haemodynamic variables (MAP, PAOP, CVP, SVR, PVR, CI), carbon dioxide production, oxygen consumption and respiratory quotient. If the patient shivered, the measurements were recorded prior to drug treatment and repeated 30 min later following randomization to either: meperidine 0.25 mg.kg-1 (Group 1), meperidine 0.5 mg.kg-1 (Group 2) or pancuronium 0.06 mg.kg-1 intravenously (Group 3). Thirty-two patients shivered and mean VO2 and VCO2 values were greater in the shivering group than in the nonshivering patients (VO2 334.8 +/- 17.6 vs. 240.5 +/- 8.8 ml.min-1; VCO2 238.8 +/- 17.2 vs 199.2 +/- 8.4 ml.min-1, P = 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Coronary Artery Bypass/adverse effects , Meperidine/therapeutic use , Pancuronium/therapeutic use , Shivering/drug effects , Analysis of Variance , Anesthesia, Intravenous , Blood Pressure/drug effects , Blood Pressure/physiology , Body Temperature/drug effects , Body Temperature/physiology , Carbon Dioxide/metabolism , Cardiac Output/drug effects , Cardiac Output/physiology , Cardiopulmonary Bypass/adverse effects , Female , Heart Arrest, Induced/adverse effects , Humans , Male , Meperidine/administration & dosage , Middle Aged , Monitoring, Physiologic , Oxygen Consumption/drug effects , Oxygen Consumption/physiology , Pancuronium/administration & dosage , Preanesthetic Medication , Shivering/physiology , Vascular Resistance/drug effects , Vascular Resistance/physiology
4.
AARN News Lett ; 41(5): 22, 1985 May.
Article in English | MEDLINE | ID: mdl-3846418
5.
Practitioner ; 197(180): 536-44, 1966 Oct.
Article in English | MEDLINE | ID: mdl-5331085

Subject(s)
Surgery, Plastic , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...